BioAtla Inc. (BCAB)
NASDAQ: BCAB
· Real-Time Price · USD
0.48
-0.03 (-5.46%)
At close: Jun 10, 2025, 3:59 PM
BioAtla Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -61.88M | -69.78M | -81.82M | -104.56M | -119.24M | -123.46M | -124.08M | -116.53M | -109.69M | -106.48M | -102.33M | -99.48M | -100.95M | -95.4M | -88.41M | -77.11M | -52.95M |
Depreciation & Amortization | 868K | 925K | 1.06M | 1.11M | 1.17M | 1.22M | 1.15M | 1.18M | 1.18M | 1.2M | 1.22M | 1.29M | 1.33M | 1.33M | 1.31M | 1.21M | 1.1M |
Stock-Based Compensation | 8.27M | 8.92M | 9.73M | 11.05M | 12.23M | 13.54M | 14.31M | 14.38M | 14.54M | 14.56M | 14.87M | 15.65M | 24.11M | 25.12M | 24.33M | 19.96M | 7.66M |
Other Working Capital | -2.77M | -915K | 3.48M | 1.32M | 492K | -604K | -4.06M | -4.72M | -5.42M | -5.56M | -7.43M | -5.88M | -6.78M | -5.69M | -2.81M | -4.4M | -2.85M |
Other Non-Cash Items | 2.21M | 15.85M | 27.38M | 57.19M | 84.37M | 73.66M | 62.94M | 39.02M | 6.95M | 12.6M | 12.81M | 6.81M | 6.75M | 3K | 506K | 4.14M | 3.54M |
Deferred Income Tax | n/a | n/a | -10.72M | -40.53M | -72.61M | -73.66M | -62.93M | -39.02M | -6.94M | -5.89M | -5.89M | -690K | -686K | -686K | -686K | 4K | n/a |
Change in Working Capital | -1.97M | -11.2M | -14.05M | -14.89M | -6.35M | 4.68M | 10.18M | 5.86M | 6.01M | 287K | -1.01M | 7.37M | 3.79M | 7.42M | 7.68M | -6.21M | -6.87M |
Operating Cash Flow | -57.4M | -71.94M | -85.08M | -107.29M | -112.19M | -104.02M | -98.44M | -95.11M | -87.94M | -90.42M | -87.02M | -75.73M | -72.36M | -62.21M | -55.27M | -58.01M | -47.51M |
Capital Expenditures | n/a | n/a | -8K | -33K | -48K | -98K | -121K | -154K | -308K | -268K | -326K | -367K | -433K | -924K | -1.23M | -1.24M | -1.07M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3K | 3K | 3K | 3K | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.00 | 3.00 | 3.00 | 3.00 | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | -8K | -33K | -48K | -98K | -121K | -154K | -305K | -265K | -323K | -364K | -433K | -924K | -1.23M | -1.24M | -1.07M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.93M |
Common Stock Repurchased | 244.01K | 244K | 243.97K | 243.9K | -156 | -259 | -229 | -270 | -282 | -571 | -4.48K | -4.38K | -4.31K | -3.91K | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 9.13M | 9.51M | 317K | 290K | 180K | 77K | 41K | -14K | -180K | -469K | -552K | -126K | 115K | -1.39M | 194.86M | 266.67M | 266.48M |
Financial Cash Flow | 9.13M | 9.51M | 198.12K | 212.08K | -12.81K | 77.00 | 61.72K | 61.67K | 61.5K | 61.21K | -3.91M | 71.23M | 71.42M | 69.51M | 269.67M | 266.67M | 269.41M |
Net Cash Flow | -48.27M | -62.42M | -84.77M | -107.03M | -112.06M | -104.04M | -36.84M | -33.6M | -26.74M | -29.47M | -91.81M | -5.32M | -1.77M | 6.37M | 213.17M | 207.43M | 220.83M |
Free Cash Flow | -57.4M | -71.94M | -85.08M | -107.32M | -112.24M | -104.11M | -98.56M | -95.27M | -88.25M | -90.69M | -87.35M | -76.1M | -72.79M | -63.14M | -56.5M | -59.25M | -48.59M |